Monopar Therapeutics Inc
NASDAQ:MNPR
Monopar Therapeutics Inc
NASDAQ:MNPR
Price:
109.09
USD
-1.12%
Market Cap:
$730.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
P
|
Perpetua Resources Corp
NASDAQ:PPTA
|
US |
|
U
|
US Bancorp
DUS:UB5
|
US |
|
S
|
Stora Enso Oyj
DUS:ENUR
|
FI |
|
I
|
Ivanhoe Mines Ltd
SWB:IYAA
|
CA |
|
N
|
Next PLC
XBER:NXG
|
UK |
|
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
JP |
|
V
|
Verisk Analytics Inc
BMV:VRSK
|
US |
|
A
|
Akzo Nobel NV
SWB:AKU1
|
NL |
|
P
|
Precious Shipping PCL
SET:PSL
|
TH |
Multiples-Based Value
The Multiples-Based Value for Monopar Therapeutics Inc (MNPR) under the Base Case is hidden
USD.
Compared with the current market price of 109.09 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MNPR Multiples-Based Value
LOCKED
